We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Say Labeling Guidance Should Apply Only to New Drugs and Biologics
Drugmakers Say Labeling Guidance Should Apply Only to New Drugs and Biologics
The FDA’s proposal that drugmakers add microbiology and pharmacogenics information to product labels should apply only to new prescription drugs and biologics, said industry experts.